1Plend AA, Friedman EA. Lymphatic system of the female genitalia. The morphologic basis of oncologic diagnosis and therapy[ J]. Major Probl Obstet Gynecol,1971,2 :223.
2Parazzini F, Valsecchi G, Bolls G, et al. Pelvic and paraortic lymphnedal status in advanced ovarian cancer and survival [ J ]. Gynecol Oncol,1999,74( 1 ) :7.
3Maruyama Y, van Nagell JR, Powell D, et al. Predictive value of specimen histology after preoperative radiotherapy in the treatment of bulky/barrel carcinoma of the cervix [ J ]. Am J Clin Oncol, 1992,15(2) :150-156.
4Monk BJ,Cha DS,Walker JL,et al. Extent of disease as an indication for pelvic radiation following radical hysterectomy and bilateral pelvic lymph node dissection in the treatment of stage 1B and IA cervical carcinoma[ J ]. Gynecol Oncol, 1994,54 ( 1 ) : 4-9.
5Sakuragi N, Satoh C, Takeda N, et al. Incidence and distribution pattern of pelvic and paranortic lymph node metastasis in patients with stages I B, II A,and II B cervical carcinoma treated with radical hysterectomy [ J ]. Cancer, 1999,85 ( 7 ) : 1547 - 1554.
6刘新民.妇产科手术学[M].第3版.北京:人民卫生出版社,2009:259.
7Agnaldo L, Femando M, Paulo T, et al. Clinieopathological features influencing pelvic lymph node metastasis and vaginal and parametrial involvement in patients with carcinoma of the cervix[ J ]. Gynecol Obstet Invest ,2005,59 ( 1 ) :92.
8Huang H J, Chang TC, Hong JH, et al. Prognostic value of age and histologic type in neoadjuvant chemotherapy plus radical surgery for bulky (>4cm) stage lb and IIa cervical carcinoma[J]. Int J Gynecol Cancer, 2003, 13(2) : 204-211.
9Bolls G, van Zainten Przybysz N, Scarfone G, et al. Determinants of response to a cisplatin-based regimen as neoadjuvant chemotherapy in stage Ib-IIb invasive cervical cancer[ J]. Gynecol Oncol, 1996, 63(1): 62-65.
10Yeh SA, Leung SW, Wang CJ. Post-operative radiotherapy in early stage carcinoma of the uterine cervix : treatment results and prognostic factors [ J ]. Gynecol Oncol, 1999,72 ( 1 ) : 10-15.
